PLSE · Nasdaq · CIK 0001625101

PULSE BIOSCIENCES, INC.

PULSE BIOSCIENCES, INC.’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 14, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $350.0K and net income of -$72.8M, according to its XBRL data on EDGAR. Its EDGAR record lists 16 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$350.0K
Net income, FY2025
-$72.8M
Form 4 filings on record, past 12 months
16

Company overview

Legal name (as filed)
PULSE BIOSCIENCES, INC.
Ticker
PLSE
SEC Central Index Key (CIK)
0001625101
Business address
HAYWARD, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#1550 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from PULSE BIOSCIENCES, INC.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.4MFY2021$700.0KFY2022$0FY2023$0FY2024$350.0KFY2025
Net income
-$63.7MFY2021-$58.5MFY2022-$42.2MFY2023-$53.6MFY2024-$72.8MFY2025
PLSE annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$1.4M$700.0K$0$0$350.0K
Net income-$63.7M-$58.5M-$42.2M-$53.6M-$72.8M
Diluted EPS-$2.28————
Total assets$54.2M$77.9M$59.2M$132.5M$94.5M
Cash and equivalents$28.6M$61.1M$44.4M$118.0M$80.7M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareBasicAndDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

PLSE latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 19, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 14, 20268-KOther events· period Oct 14, 2026Document · Index
May 11, 2026DEF 14ADefinitive proxy statement· period Jun 11, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about PULSE BIOSCIENCES, INC., by form type:

8-K ×174 ×123 ×2424B5 ×210-Q ×24/A ×2SCHEDULE 13D/A ×1DEF 14A ×110-K/A ×1
PLSE recent filings
FiledFormWhat it isOriginal
Oct 14, 20268-KOther events· period Oct 14, 2026Document · Index
Oct 7, 20268-KOther events· period Oct 7, 2026Document · Index
Sep 15, 20268-KMaterial agreement; Agreement terminated· period Sep 14, 2026Document · Index
Sep 15, 2026424B5424B5Document · Index
Sep 15, 20268-KOther events· period Sep 15, 2026Document · Index
Sep 2, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 31, 2026Document · Index
Aug 28, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 26, 2026Document · Index
Aug 28, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 8, 2026Document · Index
Aug 28, 20263Initial statement of beneficial ownership· period Apr 8, 2026Document · Index
Aug 28, 20264Statement of changes in beneficial ownership (insider trade)· period Feb 3, 2025Document · Index
Aug 28, 20263Initial statement of beneficial ownership· period Feb 3, 2025Document · Index
Aug 6, 20268-KMaterial agreement· period Aug 6, 2026Document · Index
Aug 6, 2026424B5424B5Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Jul 29, 20268-KOther events· period Jul 29, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 11, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 11, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 11, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 11, 2026Document · Index
Jun 15, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 11, 2026Document · Index
Jun 12, 20268-KShareholder vote results· period Jun 11, 2026Document · Index
Jun 10, 20268-KOther events· period Jun 10, 2026Document · Index
May 15, 20264/AStatement of changes in beneficial ownership (insider trade)· period May 11, 2026Document · Index
May 14, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 13, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
May 11, 20264/AATM PURCHASE· period May 11, 2026Document · Index
May 11, 20264ATM PURCHASE· period May 11, 2026Document · Index
May 11, 20264ATM PURCHASE· period May 11, 2026Document · Index
May 11, 2026DEF 14ADefinitive proxy statement· period Jun 11, 2026Document · Index
May 6, 20268-KOther events· period May 5, 2026Document · Index
May 4, 20268-KResults of operations; Other events· period May 4, 2026Document · Index
Apr 30, 202610-K/AAmended annual report· period Dec 31, 2025Document · Index
Apr 27, 20268-KRegulation FD disclosure· period Apr 25, 2026Document · Index
Apr 16, 20268-KRegulation FD disclosure· period Apr 16, 2026Document · Index
Apr 9, 20268-KDirector or officer change; Regulation FD disclosure· period Apr 8, 2026Document · Index
Apr 7, 20268-KOther events· period Apr 7, 2026Document · Index
Apr 3, 20264FORM 4, DARRIN (RSU GRANT)· period Mar 23, 2026Document · Index
Mar 27, 20268-KDirector or officer change· period Mar 23, 2026Document · Index
Mar 17, 20268-KOther events· period Mar 17, 2026Document · Index

Insider filing activity

16 Form 4 filings appear in PULSE BIOSCIENCES, INC.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001625101 and XBRL company facts. PULSE BIOSCIENCES, INC. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.